The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls

British Journal of Haematology

Volumn 110, Issue 2, 2000, Pages 469-471

  Endler, G ^a   Lalouschek, W ^a   Exner, M ^a   Mitterbauer, G ^a   Haring D ^a   Mannhalter, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

4G 5G promotor polymorphism; Genetic risk factors; Minor stroke; PAI 1; Transient ischaemic attack

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 0033847724     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02164.x     Document Type: Article

References (12)

1. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promotor polymorphism and levels in subjects with cerebrovascular disease
2. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasminogen activator inhibitor-1 activity
3. Allele specific increase in basal transcription of the plasminogen activator inhibitor 1 gene is associated with myocardial infaction
4. Plasminogen activator inhibitor-1 (PAI-1) promotor 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease
5. The 4G/5G polymorphism of PAI-1 promotor gene and the risk of myocardial infarction: A meta-analysis
6. Plasminogen activator inhibitor-1 (PAI-1) promotor polymorphism and coronary artery disease in non-insulin-dependent diabetes
7. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction
8. Plasminogen activator inhibitor-1 promotor 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography
9. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women
10. Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection
11. 4G/5G polymorphism of PAI-1 gene promotor and fibrinolytic capacity in patients with deep vein thrombosis
12. Classification of cerebrovascular disease III